Hydrogen sulfide may prove 'natural' anti-ageing agent

Image
Press Trust of India Washington
Last Updated : Jan 30 2013 | 3:35 PM IST

Hydrogen sulfide (H2S) supplements could become a potent natural agent to prevent and alleviate the symptoms of ageing and age-related diseases, researchers claim.

The Chinese study explores the compound's plethora of potential anti-ageing pathways.

"H2S has been gaining increasing attention as an important endogenous signalling molecule because of its significant effects on the cardiovascular and nervous systems," researchers said in journal Molecular and Cellular Biology.

The evidence is mounting, they note, that hydrogen sulfide slows ageing by inhibiting free-radical reactions, by activating SIRT1, an enzyme believed to be a regulator of lifespan, and probably through its interactions with a gene, klotho, which appears to have its own market basket of anti-ageing activity.

"Data available so far strongly suggest that H2S may become the next potent agent for preventing and ameliorating the symptoms of ageing and age-associated diseases," said said Zhi-Sheng Jiang, of the University of South China.

Researchers say people may take H2S via food, or as an anti-ageing supplement.

Hydrogen sulfide is produced within the human body, and has a variety of important physiological effects. For example, it relaxes the vascular endothelium and smooth muscle cells, which is important to maintaining clean arteries as one ages, said Jiang in a statement.

It functions as an antioxidant. And it inhibits expression of pro-inflammatory factors, all of which "imply an important role in ageing and age-associated diseases," according to the study.

For example, mice lacking CSE, the gene for an enzyme involved in producing H2S, manifest extensive, premature arteriosclerosis, an inevitable consequence of ageing, says Jiang.

The gene, klotho, which appears to be up-regulated by hydrogen sulfide, is thought to extend lifespan via a number of different pathways, some of which promote production of endogenous antioxidants, according to the report.

Produced in the kidneys, it has direct angiotensin-converting enzyme (ACE) inhibiting activity; that is, it's an ACE inhibitor, just like certain drugs that mitigate high blood pressure.

  

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jan 30 2013 | 3:35 PM IST

Next Story